Experienced in Progressive External Ophthalmoplegia

Wei F. Mao

No. 801 Heqing Rd, 
Minhang, CN 
Experienced in Progressive External Ophthalmoplegia
No. 801 Heqing Rd, 
Minhang, CN 
OverviewLocationsClinical Research

Overview

Wei Mao practices in Minhang, China. Mao is rated as an Experienced expert by MediFind in the treatment of Progressive External Ophthalmoplegia. Their top areas of expertise are Endometritis, Pelvic Inflammatory Disease, Low Blood Pressure, Cardiac Ablation, and Splenectomy.

Their clinical research consists of co-authoring 512 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Progressive External Ophthalmoplegia.

Locations

No. 801 Heqing Rd, Minhang, 200240, China
Other Locations
No. 306, Zhaowuda Road, Hohhot, 010018, China
180 Fenglin Road, Shanghai, 200032, China
Key Laboratory Of Head And Neck, Shanghai, 200080, China
No. 111 Dade Road, Guangzhou, 510120, China
54 Youdian Road, Hangzhou, 310006, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase IIa Clinical Trial on TSG-01 in the Treatment of Chronic Heart Failure in Patients With Coronary Heart Disease.
A Phase IIa Clinical Trial on TSG-01 in the Treatment of Chronic Heart Failure in Patients With Coronary Heart Disease.
Enrollment Status: Completed
Publish Date: October 26, 2022
Intervention Type: Drug
Study Drug: TSG-01 Ginsenosides
Study Phase: Phase 2

512 Total Publications

Isolation and identification of diverse steroids as Escherichia coli β-glucuronidase inhibitors from the Submerge-cultured mycelia of Hirsutella sinensis.
Isolation and identification of diverse steroids as Escherichia coli β-glucuronidase inhibitors from the Submerge-cultured mycelia of Hirsutella sinensis.
Journal: Natural product research
Published: October 10, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mao's expertise for a condition
ConditionClose
    View All 90 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile